Consulta Ltd Increases Stock Holdings in Danaher Corporation $DHR

Key Points

• Consulta Ltd increased its holdings in Danaher Corporation by 47.2% during the first quarter, now owning 883,200 shares valued at approximately $181 million.
• Danaher has received a consensus rating of "Moderate Buy" from market analysts, with an average price target of $247.61.
• In recent transactions, Danaher insiders have shown varying activity, including a director selling 2,778 shares, representing an 11.81% decrease in their position.

Consulta Ltd grew its holdings in shares of Danaher Corporation (NYSE:DHR - Free Report) by 47.2% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 883,200 shares of the conglomerate's stock after acquiring an additional 283,200 shares during the quarter. Danaher accounts for approximately 12.2% of Consulta Ltd's holdings, making the stock its 4th biggest holding. Consulta Ltd owned approximately 0.12% of Danaher worth $181,056,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. Heck Capital Advisors LLC purchased a new position in shares of Danaher during the fourth quarter worth approximately $27,000. GHP Investment Advisors Inc. raised its stake in shares of Danaher by 396.0% during the first quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock worth $25,000 after acquiring an additional 99 shares in the last quarter. Sierra Ocean LLC raised its stake in shares of Danaher by 116.9% during the first quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate's stock worth $29,000 after acquiring an additional 76 shares in the last quarter. Smallwood Wealth Investment Management LLC purchased a new position in shares of Danaher during the first quarter worth approximately $31,000. Finally, Dunhill Financial LLC raised its stake in shares of Danaher by 68.4% during the first quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate's stock worth $34,000 after acquiring an additional 67 shares in the last quarter. 79.05% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Danaher

In other news, Director Teri List sold 2,778 shares of the business's stock in a transaction on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total transaction of $586,324.68. Following the sale, the director owned 20,751 shares in the company, valued at approximately $4,379,706.06. The trade was a 11.81% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Company insiders own 11.20% of the company's stock.

Analysts Set New Price Targets

DHR has been the topic of several recent analyst reports. Wells Fargo & Company cut their target price on shares of Danaher from $210.00 to $205.00 and set an "equal weight" rating on the stock in a report on Wednesday, July 23rd. Robert W. Baird raised their target price on shares of Danaher from $225.00 to $226.00 and gave the stock an "outperform" rating in a report on Friday, July 18th. UBS Group cut their target price on shares of Danaher from $240.00 to $225.00 and set a "buy" rating on the stock in a report on Wednesday, July 23rd. Scotiabank upgraded shares of Danaher from a "sector perform" rating to a "sector outperform" rating and set a $275.00 target price on the stock in a report on Friday, July 11th. Finally, Royal Bank Of Canada set a $241.00 target price on shares of Danaher in a report on Tuesday. Seventeen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat, Danaher presently has a consensus rating of "Moderate Buy" and a consensus price target of $246.35.

Danaher Trading Down 1.6%

NYSE:DHR traded down $3.19 during trading hours on Wednesday, hitting $200.60. The company had a trading volume of 1,167,179 shares, compared to its average volume of 4,142,949. The company has a market capitalization of $143.64 billion, a PE ratio of 42.71, a price-to-earnings-growth ratio of 2.87 and a beta of 0.75. The stock has a 50-day moving average price of $201.97 and a 200 day moving average price of $199.49. Danaher Corporation has a 52 week low of $171.00 and a 52 week high of $279.90. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.62 and a quick ratio of 1.22.

Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, beating the consensus estimate of $1.64 by $0.16. The business had revenue of $5.94 billion for the quarter, compared to analysts' expectations of $5.83 billion. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The firm's revenue for the quarter was up 3.4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.72 earnings per share. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. On average, equities research analysts predict that Danaher Corporation will post 7.63 EPS for the current fiscal year.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.